TITLE

Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells

AUTHOR(S)
Müller, Rebekka; Misund, Kristine; Holien, Toril; Bachke, Siri; Gilljam, Karin M.; Våtsveen, Thea K.; Rø, Torstein B.; Bellacchio, Emanuele; Sundan, Anders; Otterlei, Marit
PUB. DATE
July 2013
SOURCE
PLoS ONE;Jul2013, Vol. 8 Issue 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Multiple myeloma is a hematological cancer that is considered incurable despite advances in treatment strategy during the last decade. Therapies targeting single pathways are unlikely to succeed due to the heterogeneous nature of the malignancy. Proliferating cell nuclear antigen (PCNA) is a multifunctional protein essential for DNA replication and repair that is often overexpressed in cancer cells. Many proteins involved in the cellular stress response interact with PCNA through the five amino acid sequence AlkB homologue 2 PCNA-interacting motif (APIM). Thus inhibiting PCNA’s protein interactions may be a good strategy to target multiple pathways simultaneously. We initially found that overexpression of peptides containing the APIM sequence increases the sensitivity of cancer cells to contemporary therapeutics. Here we have designed a cell-penetrating APIM-containing peptide, ATX-101, that targets PCNA and show that it has anti-myeloma activity. We found that ATX-101 induced apoptosis in multiple myeloma cell lines and primary cancer cells, while bone marrow stromal cells and primary healthy lymphocytes were much less sensitive. ATX-101-induced apoptosis was caspase-dependent and cell cycle phase-independent. ATX-101 also increased multiple myeloma cells’ sensitivity against melphalan, a DNA damaging agent commonly used for treatment of multiple myeloma. In a xenograft mouse model, ATX-101 was well tolerated and increased the anti-tumor activity of melphalan. Therefore, targeting PCNA by ATX-101 may be a novel strategy in multiple myeloma treatment.
ACCESSION #
89628997

 

Related Articles

  • Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Bellacosa, A // Cell Death & Differentiation;Nov2001, Vol. 8 Issue 11, p1076 

    The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembling of multimeric complexes involved in mismatch...

  • Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma. Dimberg, Lina Y.; Dimberg, Anna; Ivarsson, Karolina; Fryknäs, Mårten; Rickardson, Linda; Tobin, Gerard; Ekman, Simon; Larsson, Rolf; Gullberg, Urban; Nilsson, Kenneth; ™berg, Fredrik; Wiklund, Helena Jernberg // BMC Cancer;2012, Vol. 12 Issue 1, p318 

    Background: Multiple myeloma (MM) is at present an incurable malignancy, characterized by apoptosis-resistant tumor cells. Interferon (IFN) treatment sensitizes MM cells to Fas-induced apoptosis and is associated with an increased activation of Signal transducer and activator of transcription...

  • Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells. DONGHONG JU; YOUMING XIE // Molecular Medicine Reports;2014, Vol. 10 Issue 5, p2609 

    The proteasome has become an important target for cancer therapy with the approval of bortezomib for the treatment of relapsed/refractory multiple myeloma (MM). However, numerous patients with MM do not respond to bortezomib and those responding initially often acquire resistance. Recent...

  • A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway. Bhattacharjee, Mitali; Raju, Rajesh; Radhakrishnan, Aneesha; kshiNanjappa, Vishala; Muthusamy, Babylakshmi; Singh, Kamlendra; Kuppusamy, Dheebika; Lingala, Bhavya Teja; Pan, Archana; Mathur, Premendu Prakash; Harsha, H. C.; Prasad, T. S. Keshava; Atkins, Gerald J.; Pandey, Akhilesh; Chatterjee, Aditi // Journal of Signal Transduction;2012, p1 

    TNF-related weak inducer of apoptosis (TWEAK) is a new member of the TNF superfamily. It signals through TNFRSF12A, commonly known as Fn14. The TWEAK-Fn14 interaction regulates cellular activities including proliferation, migration, differentiation, apoptosis, angiogenesis, tissue remodeling and...

  • Regulation of Caenorhabditis elegans p53/CEP-1--Dependent Germ Cell Apoptosis by Ras/MAPK Signaling. Rutkowski, Rachael; Dickinson, Robin; Stewart, Graeme; Craig, Ashley; Schimpl, Marianne; Keyse, Stephen M.; Gartner, Anton // PLoS Genetics;Aug2011, Vol. 7 Issue 8, Special section p1 

    Maintaining genome stability in the germline is thought to be an evolutionarily ancient role of the p53 family. The sole Caenorhabditis elegans p53 family member CEP-1 is required for apoptosis induction in meiotic, late-stage pachytene germ cells in response to DNA damage and meiotic...

  • Changing the Subcellular Location of the Oncoprotein Bcr-Abl Using Rationally Designed Capture Motifs. Dixon, Andrew; Constance, Jonathan; Tanaka, Tomoyuki; Rabbitts, Terence; Lim, Carol // Pharmaceutical Research;Apr2012, Vol. 29 Issue 4, p1098 

    Purpose: Bcr-Abl, the causative agent of chronic myelogenous leukemia (CML), localizes in the cytoplasm where its oncogenic signaling leads to proliferation of cells. If forced into the nucleus Bcr-Abl causes apoptosis. To achieve nuclear translocation, binding domains for capture of Bcr-Abl...

  • FHL1C induces apoptosis in notch1-dependent T-ALL cells through an interaction with RBP-J. Wei Fu; Kai Wang; Jun-Long Zhao; Heng-Chao Yu; San-Zhong Li; Yan Lin; Liang Liang; Si-Yong Huang; Ying-Min Liang; Hua Han; Hong-Yan Qin // BMC Cancer;2014, Vol. 14 Issue 1, p178 

    Background Aberrantly activated Notch signaling has been found in more than 50% of patients with T-cell acute lymphoblastic leukemia (T-ALL). Current strategies that employ γ-secretase inhibitors (GSI) to target Notch activation have not been successful. Many limitations, such as non-Notch...

  • The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function. COOTHANKANDASWAMY, Veena; ELANGOVAN, Selvakumar; SINGH, Nagendra; PRASAD, Puttur D.; THANGARAJU, Muthusamy; GANAPATHY, Vadivel // Biochemical Journal;2/15/2013, Vol. 450 Issue 1, following p169 

    SLC5A8 (solute carrier gene family 5A, member 8) is a sodium-coupled transporter for monocarboxylates. Among its substrates are theHDAC (histone deacetylase) inhibitors butyrate, propionate and pyruvate. Expression of SLC5A8 is silenced in cancers via DNA methylation, and ectopic expression of...

  • Literature-Based Automated Reconstruction, Expansion, and Refinement of the TGF-β Superfamily Ligand-Receptor Network. Mei, Qian; Saiz, Leonor // Journal of Membrane Biology;May2014, Vol. 247 Issue 5, p381 

    The TGF-β pathway transduces a variety of extracellular signals into intracellular responses that control multiple cellular processes, including cell growth, apoptosis, and differentiation. It encompasses 33 ligands that interact with 7 type II receptors and 5 type I receptors at the plasma...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics